miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple Sclerosis

Cognitive deficits strongly affect the quality of life of patients with multiple sclerosis (MS). However, no cognitive MS biomarkers are currently available. Extracellular vesicles (EVs) contain markers of parental cells and are able to pass from the brain into blood, representing a source of diseas...

Full description

Saved in:
Bibliographic Details
Published in:Cells (Basel, Switzerland) Switzerland), 2022-05, Vol.11 (9), p.1551
Main Authors: Scaroni, Federica, Visconte, Caterina, Serpente, Maria, Golia, Maria Teresa, Gabrielli, Martina, Huiskamp, Marijn, Hulst, Hanneke E, Carandini, Tiziana, De Riz, Milena, Pietroboni, Anna, Rotondo, Emanuela, Scarpini, Elio, Galimberti, Daniela, Teunissen, Charlotte E, van Dam, Maureen, de Jong, Brigit A, Fenoglio, Chiara, Verderio, Claudia
Format: Article
Language:English
Subjects:
Biomarkers
Blood
Cognition
Cognition & reasoning
Cognitive ability
cognitive deficits
Disease
Executive function
Extracellular vesicles
Extracellular Vesicles - genetics
Humans
Memory
microRNAs
MicroRNAs - genetics
miRNA
Multiple sclerosis
Multiple Sclerosis - genetics
myeloid extracellular vesicles
Neuropsychology
Non-coding RNA
Patients
plasma extracellular vesicles
Quality of Life
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cognitive deficits strongly affect the quality of life of patients with multiple sclerosis (MS). However, no cognitive MS biomarkers are currently available. Extracellular vesicles (EVs) contain markers of parental cells and are able to pass from the brain into blood, representing a source of disease biomarkers. The aim of this study was to investigate whether small non-coding microRNAs (miRNAs) targeting synaptic genes and packaged in plasma EVs may reflect cognitive deficits in MS patients. Total EVs were precipitated by Exoquick from the plasma of twenty-six cognitively preserved (CP) and twenty-three cognitively impaired (CI) MS patients belonging to two independent cohorts. Myeloid EVs were extracted by affinity capture from total EVs using Isolectin B4 (IB4). Fourteen miRNAs targeting synaptic genes were selected and measured by RT-PCR in both total and myeloid EVs. Myeloid EVs from CI patients expressed higher levels of miR-150-5p and lower levels of let-7b-5p compared to CP patients. Stratification for progressive MS (PMS) and relapsing-remitting MS (RRMS) and correlation with clinical parameters suggested that these alterations might be attributable to cognitive deficits rather than disease progression. This study identifies miR-150-5p and let-7b-5p packaged in blood myeloid EVs as possible biomarkers for cognitive deficits in MS.
ISSN:2073-4409
2073-4409
DOI:10.3390/cells11091551